# Cadre Holdings, Inc.: filings

CDRE · NYSE · CIK 1860543 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cdre.md) · [Financials](/companies/cdre/financials.md) · [Filings](/companies/cdre/filings.md) · [Insiders](/companies/cdre/insiders.md)

## Reports and events: 89 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 150, 8-K 46, 144 45, CORRESP 18, 424B3 16, 10-Q 15, 3 11, UPLOAD 11, SCHEDULE 13G/A 9, S-1/A 8, SC 13G/A 6, 10-K 5, DEF 14A 5, EFFECT 5, ARS 4, SC 13G 4, 4/A 3, 8-K/A 3, S-1 3, SCHEDULE 13D/A 3, SD 3, 3/A 2, 424B4 2, 424B5 2, 424B7 2, 5 2, 8-A12B 2, CERT 2, DRS 2, S-1MEF 2, S-8 2, SCHEDULE 13G 2, DEFA14A 1, DRS/A 1, DRSLTR 1, RW 1, S-3 1, S-3/A 1, S-3ASR 1, S-3MEF 1, S-4 1, S-4/A 1, SCHEDULE 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-30 | 19:47 ET | [SCHEDULE 13D/A](/filings/0001104659-26-112476.md) | Ownership report, active investor, amended | 0001104659-26-112476 |
| 2026-08-07 | 16:15 ET | [8-K/A](/filings/0001104659-26-092721.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-092721 |
| 2026-08-05 | 16:28 ET | [10-Q](/filings/0001104659-26-091151.md) | Quarterly report, period 2026-06-30 | 0001104659-26-091151 |
| 2026-08-05 | 16:25 ET | [8-K](/filings/0001104659-26-091143.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-091143 |
| 2026-07-29 | 16:15 ET | [8-K](/filings/0001104659-26-088148.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-26-088148 |
| 2026-06-18 | 16:20 ET | [SCHEDULE 13D/A](/filings/0001104659-26-075751.md) | Ownership report, active investor, amended | 0001104659-26-075751 |
| 2026-06-03 | 16:15 ET | [8-K](/filings/0001104659-26-070114.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001104659-26-070114 |
| 2026-05-11 | 16:18 ET | [10-Q](/filings/0001104659-26-058670.md) | Quarterly report, period 2026-03-31 | 0001104659-26-058670 |
| 2026-05-11 | 16:15 ET | [8-K](/filings/0001104659-26-058660.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-058660 |
| 2026-04-24 | 08:30 ET | [DEF 14A](/filings/0001104659-26-048191.md) | Proxy statement, period 2026-05-29 | 0001104659-26-048191 |
| 2026-03-10 | 16:19 ET | [10-K](/filings/0001104659-26-025862.md) | Annual report, period 2025-12-31 | 0001104659-26-025862 |
| 2026-03-10 | 16:15 ET | [8-K](/filings/0001104659-26-025848.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-025848 |
| 2026-02-02 | 08:30 ET | [8-K/A](/filings/0001104659-26-008994.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-26-008994 |
| 2025-11-19 | 16:15 ET | [SCHEDULE 13D/A](/filings/0001104659-25-114105.md) | Ownership report, active investor, amended | 0001104659-25-114105 |
| 2025-11-14 | 16:15 ET | [SCHEDULE 13D](/filings/0001104659-25-112538.md) | Ownership report, active investor | 0001104659-25-112538 |
| 2025-11-04 | 16:17 ET | [10-Q](/filings/0001104659-25-106299.md) | Quarterly report, period 2025-09-30 | 0001104659-25-106299 |
| 2025-11-04 | 16:15 ET | [8-K](/filings/0001104659-25-106290.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-106290 |
| 2025-11-03 | 16:16 ET | [8-K](/filings/0001104659-25-105558.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-25-105558 |
| 2025-10-29 | 08:35 ET | [8-K](/filings/0001104659-25-103556.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-103556 |
| 2025-10-08 | 08:30 ET | [8-K](/filings/0001104659-25-097750.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-097750 |
| 2025-08-05 | 16:16 ET | [10-Q](/filings/0001558370-25-010299.md) | Quarterly report, period 2025-06-30 | 0001558370-25-010299 |
| 2025-08-05 | 16:15 ET | [8-K](/filings/0001558370-25-010294.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-010294 |
| 2025-06-05 | 16:47 ET | [8-K](/filings/0001104659-25-056881.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-25-056881 |
| 2025-05-06 | 16:17 ET | [10-Q](/filings/0001558370-25-006502.md) | Quarterly report, period 2025-03-31 | 0001558370-25-006502 |
| 2025-05-06 | 16:15 ET | [8-K](/filings/0001558370-25-006500.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-006500 |
| 2025-04-24 | 16:15 ET | [DEF 14A](/filings/0001104659-25-038649.md) | Proxy statement, period 2025-05-30 | 0001104659-25-038649 |
| 2025-03-11 | 16:18 ET | [10-K](/filings/0001558370-25-002711.md) | Annual report, period 2024-12-31 | 0001558370-25-002711 |
| 2025-03-11 | 16:15 ET | [8-K](/filings/0001558370-25-002709.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-002709 |
| 2025-01-27 | 16:16 ET | [8-K](/filings/0001104659-25-006329.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-25-006329 |
| 2025-01-21 | 16:15 ET | [8-K](/filings/0001104659-25-004898.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-25-004898 |
| 2025-01-16 | 07:44 ET | [8-K](/filings/0001104659-25-003946.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-003946 |
| 2025-01-15 | 16:15 ET | [8-K](/filings/0001104659-25-003767.md) | 5.02 Departure or appointment of officers or directors | 0001104659-25-003767 |
| 2024-12-23 | 16:15 ET | [8-K](/filings/0001104659-24-131303.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-24-131303 |
| 2024-11-08 | 16:15 ET | [8-K](/filings/0001104659-24-115878.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-24-115878 |
| 2024-11-06 | 16:20 ET | [10-Q](/filings/0001558370-24-014638.md) | Quarterly report, period 2024-09-30 | 0001558370-24-014638 |
| 2024-11-06 | 16:15 ET | [8-K](/filings/0001558370-24-014629.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-014629 |
| 2024-08-09 | 16:17 ET | [10-Q](/filings/0001558370-24-011750.md) | Quarterly report, period 2024-06-30 | 0001558370-24-011750 |
| 2024-08-09 | 16:15 ET | [8-K](/filings/0001558370-24-011748.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-011748 |
| 2024-07-19 | 16:19 ET | [8-K](/filings/0001104659-24-081176.md) | 8.01 Other events | 0001104659-24-081176 |
| 2024-06-04 | 16:21 ET | [8-K](/filings/0001104659-24-068258.md) | 5.07 Shareholder vote results | 0001104659-24-068258 |
| 2024-05-08 | 16:16 ET | [10-Q](/filings/0001558370-24-007349.md) | Quarterly report, period 2024-03-31 | 0001558370-24-007349 |
| 2024-05-07 | 16:15 ET | [8-K](/filings/0001558370-24-007054.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-007054 |
| 2024-04-29 | 16:15 ET | [DEF 14A](/filings/0001104659-24-054037.md) | Proxy statement, period 2024-05-31 | 0001104659-24-054037 |
| 2024-03-19 | 16:16 ET | [8-K](/filings/0001104659-24-036150.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-24-036150 |
| 2024-03-12 | 16:32 ET | [10-K](/filings/0001558370-24-002995.md) | Annual report, period 2023-12-31 | 0001558370-24-002995 |
| 2024-03-06 | 16:05 ET | [8-K](/filings/0001104659-24-031464.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-24-031464 |
| 2024-03-05 | 16:17 ET | [8-K](/filings/0001558370-24-002481.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-002481 |
| 2024-02-23 | 16:15 ET | [8-K](/filings/0001104659-24-027033.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-24-027033 |
| 2024-02-20 | 16:37 ET | [8-K](/filings/0001104659-24-025573.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-025573 |
| 2023-12-29 | 16:15 ET | [8-K](/filings/0001104659-23-130479.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-23-130479 |

Page 1 of 2. [Older](/companies/cdre/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.